Gen9 is the premier next-generation gene synthesis company focused on high-quality, high-throughput, automated production of DNA constructs. Currently, Gen9 offers multiple synthetic biology solutions for researchers who need high quality clonal, sequence-perfect DNA. Our award winning BioFab® process is remarkably flexible and very high throughput; allowing us to make the genes you need quickly at the highest quality available. Gen9 is Powering the Synthetic Biology Revolution.

Cambridge, US
43 (est)-2%

Gen9 Locations

Cambridge, US

Gen9 Metrics

Gen9 Summary

Founding Date


Total Funding

$50.1 M

Latest funding size

$25 M

Time since last funding

about 2 years


Gen9 Company Life